Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Becton Dickson is the NJ-based syringe manufacturer that stepped up to take on COVID-19

In the early stages of the COVID pandemic, as most of the world sought hope amid soaring death tolls and sinking economies, a New Jersey company looked ahead and readied itself for the moment when a medical solution would arrive. Anticipating the development of vaccines as well as a red-hot worldwide demand for its products, Becton Dickinson, the world′s leading syringe manufacturer, ramped up production at plants in the U.S., Asia, and Europe early in 2020. Hundreds of millions of orders poured in from across the globe and in response, the Franklin Lakes-based company produced 1 billion more needles and syringes than in a typical year, an increase of more than 2,000 a minute.